Originalarbeiten:

  • A. Behrens, A. Kreuzmayr, H. Manner, H. Koop, A. Lorenz, C. Schaefer, M. Plauth, J.U. Jetschmann, C. v. Tirpitz, M. Ewald, M. Sackmann, W. Renner, M. Krüger, D. Schwab, W. Hoffmann, O. Engelke, O. Pech, F. Kullmann, S. Pampuch, B. Lenfers, U. Weickert, D. Schilling, S. Boehm, S. Beckebaum, V. Cicinnati, J.F. Erckenbrecht, F. L. Dumoulin, C. Benz, T. Rabenstein, G. Haltern, M. Balsliemke, C. de Mas, G. Kleber, C. Pehl, C. Vogt, R. Kiesslich,W. Fischbach, I. Koop, J. Kuehne, M. Breidert, N. L. Sass, A. May, C. Friedrich, R. Veitt, R. Porschen, M. Ellrichmann, A. Arlt, W. Schmitt, M. Dollhopf, W. Schmidbaur, A. Dignass, V. Schmitz, J. Labenz, G. Kaiser, A. Krannich, N. Barteska, C. Ell. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut. Jan 3. pii: gutjnl-2015-311037. doi: 10.1136/gutjnl-2015-311037. PubMed PMID: 29298872. 2018 
    JIF: 16,65


  • Weissinger, M. Reymond, K. Dumke, M. Krüger. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). Onkologie;34(10):548-51. doi: 10.1159/000332226. Epub 2011 Sep 19. PubMed PMID: 21985855. 2011 
    JIF: 1,52


  • Bert T. te Wildt, C. Tettenborn, U. Schneider, MD. Ohlmeier, M. Zedler, M. Krüger. Swallowing foreign bodies as an example of impulse control disorder in a patient with intellectual disabilities: a case report. Psychiatry (Edgmont); 7(9): 34–37, 2010 
    JIF: 1,56


  • C. Wang, A. Heim, V. Schlaphoff, PV Suneetha, KA Stegmann, H Jiang, M. Krüger, P. Fytili, T. Schulz, M. Cornberg, R. Kandolf, M.P. Manns, C.T. Bock, H. Wedemeyer. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis. Journal of Medical Virology, Dec;81(12):2079-88, 2008 
    JIF: 3,35


  • M. Korf, A. Meyer, D. Jarczak, C. Beger, M.P. Manns, M. Krüger. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters. Journal of Viral Hepatitis, Feb;14(2):122-32, 2007 
    JIF: 3,30


  • J.J. W. Tischendorf, P.N. Meier, A. Schneider, M.P. Manns, M. Krüger. Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology, Aug;42(8):1011-7, 2007 
    JIF: 2,52


  • A. Schneider, J. Wedemeyer, P.N. Meier, M. Mengel, M.P. Manns, M. Krüger. Immunsuppressive Therapie bei steroidrefraktärem Pemphigoid des Ösophagus. Endo heute, 01: 20, 72-74, 2007 (Fallbericht)
    JIF: 0,188


  • J.J.W. Tischendorf, M. Krüger, H. Hecker, M.P. Manns, P.N. Meier. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. American Journal of Gastroenterology. Jan;102(1):107-14, 2007 
    JIF: 10,755

  • A. Hafer, S. Krämer, S. Duncker, M. Krüger, M.P. Manns, S.C. Bischoff. Effects of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease. BMC Gastroenterology, Sep 4;7:36.A, 2007 
    JIF: 2,365


  • J. J. W. Tischendorf, P. N. Meier, C. Straßburg, J. Klempnauer, H. Hecker, M. P. Manns, M. Krüger. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. Oct;41(10):1227-34, 2006 
    JIF: 2,361


  • S. Ciesek, M. P. Manns, M. Krüger. Retroperitonealabszess bei schwerer nekrotisierender Pankreatitis: ein Beispiel für praktizierte Viszeralmedizin. Deutsche Medizinische Wochenschrift, S131(36):1937-40, 2006 
    JIF: 0,552


  • M.P. Manns, M. Krüger. Viszeralmedizin – Zukunft der Gastroenterologie und Viszeralchirurgie? Deutsche Medizinische Wochenschrift, 131:1929, 2006 (Editorial) 
    JIF: 0,552

  • J.J. W. Tischendorf*, M. Krüger*, C. Trautwein, N. Duckstein, A. Schneider, M. P. Manns P. N. Meier. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy, 38(7):665-9, 2006 Erratum in: Endoscopy, 38(8):852, 2006 *both authors contributed equally 
    JIF: 5,196

  • I. Köllner, B. Sodeik, S. Schreek, H. Heyn, N. von Neuhoff, M. Germeshausen, C. Zeidler, M. Krüger, B. Schlegelberger, K. Welte, C. Beger. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood, 15;108(2):493-500, 2006
    JIF: 13,164


  • M. Krüger, A. Schneider, M.P. Manns, P. N. Meier. Endoscopic management of pancreatic pseudocysts or pancreatic abscesses after an EUS-guided one step-procedure for initial access. Gastrointestinal Endoscopy, 63(3):409-16, 2006 
    JIF: 6,501


  • P. Kuempers, L. Köhler, S. Pertschy, M. Krüger, H. Zeidler, J. Freise. Unilateral fasciitis of the lower leg - paraneoplastic manifestation of an occult pancreatic tumor. Journal of Clinical Rheumatology, 12(3):139-41, 2006
    JIF: 1,322


  • D. Jarczak, M. Korf, C. Beger, M.P. Manns, M. Krüger. Hairpin ribozymes combined with siRNAs strongly inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. FEBS Journal, 272:5910–5922, 2005
    JIF: 3,902


  • M. Korf, D. Jarczak, C. Beger, M.P. Manns, M. Krüger. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. Journal of Hepatology, 43:225–234, 2005 
    JIF: 12,486


  • A. Schneider, M. Krüger, M.J. Bahr, K. Rifai, M.P. Manns, P.N. Meier. Akute Pankreatitis nach endoskopischer Duodenalbiopsie. Endoskopie heute, 17: 213-215, 2004
    JIF: 0,188


  • M. Krüger, J. Behrens, F. Länger, M. P. Manns, P.N. Meier. Intramucosal adenocarcinoma of the appendix. Endoscopy, 36: 565-566, 2004
    JIF: 5,196


  • C. Beger, M. Ramadani, S. Meyer, G. Leder, M. Krüger, K. Welte, F. Gansauge, H.G. Beger. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma. Clinical Cancer Research, 10(11):3780-3787, 2004
    JIF: 9,619


  • J.J.W. Tischendorf, C. Beger, M. Korf, M.P. Manns, M. Krüger. Polypyrimidine tract-binding protein (PTB) inhibits Hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation, but does not affect HCV replication. Archives of Virology. 149: 1955-1970, 2004
    JIF: 2,39


  • H.L. Tillmann, C. Trautwein, T. Bock, I. Glomb, M. Krüger, K.H.W. Böker, J. Klempnauer, P Flemming, M.P. Manns. Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis. American Journal of Gastroenterology. 97:777-778, 2002
    JIF: 10,755


  • M. Krüger, C. Beger, P. J. Welch, J. R. Barber, M. P. Manns, F. Wong-Staal. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Molecular and Cellular Biology. 21:8357-8364, 2001
    JIF: 5,036


  • M. Krüger, C. Beger, P. J. Welch, J. R. Barber, F. Wong-Staal 2001. C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification. Nucleic Acids Research. 29:E94 1-7, 2001
    JIF: 10,162


  • C. Beger, L. Pierce, M. Krüger, E. G. Marcusson, J. M. Robbins, P. Welcsh, P.J. Welch, K. Welte, M.-C. King, J. R. Barber, F. Wong-Staal. Identification of Id4 as a regulator of BRCA1 expression using a ribozyme-library based inverse genomics approach. Proceedings of the National Academy of Science USA. 98:130-135, 2001
    JIF: 9,809


  • M. Krüger, C. Beger, Q. X. Li, P. J. Welch, R. Tritz, M. Leavitt, J. R. Barber, F. Wong-Staal. Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. Proceedings of the National Academy of Science USA. 15:8566-8571, 2000
    JIF: 9,809


  • P.J. Welch, E. G. Marcusson, Q. X. Li, C. Beger, M. Krüger, C. Zhou, M. Leavitt, F. Wong-Staal, J. R. Barber. Identification and validation of a gene involved in anchorage- independent cell growth control using a library of randomized hairpin ribozymes. Genomics. 3:274-283, 2000
    JIF: 2,801


  • M. Krüger, K. Altland, R.P. Linke, H.J. Maschek, B. Ringe, G. Oehler, R. Pichlmayr, M.P. Manns. Lebertransplantation bei Familiärer Amyloid Polyneuropathie: Fallbericht und Literaturübersicht. Internist. 38: 692-700, 1997
    JIF: 0,406


  • M. Krüger, K. Altland, R.P. Linke, H.J. Maschek, G. Oehler, R. Pichlmayr, M.P. Manns. Lebertransplantation bei Familiärer Amyloid Polyneuropathie. Nervenarzt. 203-204, 1997
    JIF: 0,872


  • Czaja, A. J., M. Krüger, Santrach, P. J., Moore, S. B., M.P. Manns Genetic distinctions between types 1 and 2 autoimmune hepatitis. American Journal of Gastroenterology. 92(12): 2197-2200, 1997
    JIF: 10,383


  • M. Krüger, H.L. Tillmann, C. Trautwein, U. Bode, K. Oldhafer, H.J. Maschek, K.H.W. Böker, C. Broelsch, R. Pichlmayr, M.P. Manns. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation: a pilot study. Liver Transplantation and Surgery. 253-262, 1996
    JIF: 2,75


  • M. Krüger, K.H.W. Böker, H. Zeidler, M.P. Manns. Treatment of Hepatitis B-related panarteriitis nodosa with famciclovir and interferon alfa-2b. Journal of Hepatology. 26: 935-939, 1996
    JIF: 12,486


  • H.L. Tillmann, M. Krüger, U. Bode, C. Trautwein. Das Problem der Virushepatitis in der Transplantationsmedizin. Internist. 240-249, 1996
    JIF: 0,406


  • M. Krüger, M.P. Manns. Liver transplantation and hepatitis B: prophylaxis and treatment of reinfection with new antiviral agents. Antiviral Therapy, 1:4, 71-75, 1996
    JIF: 3,143


  • K.H.W. Böker, B. Ringe, M. Krüger, R. Pichlmayr, M.P. Manns. Prostaglandin E plus Famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation. 1706-1708, 1994
    JIF: 3,678


  • M.P. Manns, M. Krüger. Lebertransplantation als praktizierte Gentherapie - eine Kontroverse. Internist. 330-336, 1994 (Editorial)
    JIF: 0,406

  • M.P. Manns, M. Krüger. Immunogenetics of chronic liver diseases. Gastroenterology. 1676-1697, 1994
    JIF: 18,392


  • R.O. Mirimanoff, M. Sinzig, M. Krüger, R. Miralbell et al. Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy. International Journal of Radiation Oncology Biology Physics. 17-23, 1993
    JIF: 5,133


  • H. Frieß, M. Büchler, M. Krüger, H.G. Beger. Treatment of duct carcinoma of the pancreas with the LH-RH analogue Buserelin. Pancreas. 7: 516-521, 1992
    JIF: 3,008


  • H. Frieß, M. Büchler. L. Kiesel, M. Krüger, H.G. Beger. LH-RH receptors in the human pancreas: Basis for antihormonal treatment in ductal carcinoma of the pancreas. International Journal of Pancreatology. 151-159, 1991
    JIF: 1,35 

Buchbeiträge:

  • M. Krüger. Perkutane transhepatische Gallenwegsdarstellung und Gallenwegsdrainage, in: Lehratlas der interventionellen Sonographie, Thieme 2005

  • M. Krüger. Molekularbiologie des Hepatitis C Virus, in: Hepatitis C, Unimed Verlag 2003

  • M. Krüger. Modelle der Hepatitis C Virusinfektion, in: Hepatitis C, Unimed Verlag 2003

  • M. Krüger. Perspektiven in der Therapie der Hepatitis C Virusinfektion, in: Hepatitis C, Unimed Verlag 2003

  • M. Krüger. European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis after liver transplantation. Clincal Transplantation. 14: Suppl 2:14-19, 2000

  • R.P. Perillo, M. Krüger, T. Sievers, J.R. Lake. Posttransplantation: Emerging and future therapies. Seminars in Liver Disease. 20: Suppl.1:13-17, 2000

  • M. Krüger, C. Beger, F. Wong-Staal. Use of ribozymes to inhibit gene expression. Methods in Enzymology. 306: 207-225, 1999 

  • C. Beger, M. Krüger, F. Wong-Staal. Ribozymes in cancer gene therapy. in: E. C. Lattime and S. L. Gerson (eds.). Gene therapy of cancer. pp. 139-152. San Diego: Academic Press, 1998